Semaglutide

Taking oral semaglutide may reduce heart-related hospitalizations and deaths among those with a history of heart failure and type 2 diabetes, a new analysis suggests. Data from a trial funded …

Credit: CC0 Public Domain For those with type 2 diabetes who have knee osteoarthritis, getting a knee replacement can be difficult because they are more likely to have surgical complications. …

Ozempic is a new once a week injection to treat type 2 diabetes. It’s probably one of the more common advertised medications …

A research team at Mass General Brigham has released new evidence directly comparing how well tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) protect the heart. According to the analysis, both …

New real-world evidence from the Netherlands shows that oral semaglutide meaningfully improves blood sugar and body weight in routine diabetes care, confirming clinical trial benefits in everyday practice. Study: Real-world …

Specialty Please choose I’m not a medical professional. Allergy and Immunology Anatomy Anesthesiology Biostatistics Cardiac/Thoracic/Vascular Surgery Cardiology Critical Care Dentistry Dermatology Diabetes and Endocrinology Emergency Medicine Epidemiology and Public Health …

Innovent Biologics, Inc.’s investigative GLP-1/glucagon (GCG) dual receptor agonist mazdutide has met its primary endpoint of superiority to semaglutide in HbA1c and body weight reduction in patients with type 2 …

SHANGHAI, Oct 27 (Reuters) – China’s Innovent Biologics (1801.HK)opens new tabsaidopens new tabon Monday its GLP-1 injection led to more weight loss and better control of blood sugar in patients …

Key results and new insights from the Stride trials, as well as the evolutionary role of GLP-1 receptor agonist (RA) therapy in type 2 diabetes (T2D) and peripheral arterial disease …

Editor's Note: This article has been edited to clarify the title of Dr. Galimella as MBBS, MPH. In an interview with Pharmacy Times®, Pranav Garimella, MBBS, MPH, chief medical officer …